The Patent Finder

Eutilex Co., Ltd.

Also on record
Records under this name other than the patents Eutilex Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.

Showing 1 to 4 of 4 · Back to Eutilex Co., Ltd.

PatentTitleStatus Expires Confidence
US 11,396,555Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
Lapsed on the fee record
Ended Jul 26, 2026 · High confidence
Lapsed on the fee recordEnded Jul 26, 2026High confidence
US 11,072,646Epitope for switching to TH1 cell and use thereof
Lapsed on the fee record
Ended Jul 27, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 27, 2025From the USPTO record
US 11,053,298Epitope for switching to TH2 cell and use thereof
Lapsed on the fee record
Ended Jul 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 6, 2025From the USPTO record
US 10,919,976IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof
Lapsed on the fee record
Ended Feb 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited